1,282 results match your criteria: "Eccrine Carcinoma"
Indian J Otolaryngol Head Neck Surg
April 2024
Department of Pathology, Hitkarini Dental College and Hospital, Jabalpur, India.
Primary Mucinous eccrine carcinoma (MEC) is a rare malignant neoplasm of skin believed to arise from eccrine sweat gland commonly with periocular involvement. Here we report a case of 60-year male with a recurrence of unilateral nasomaxillary mass and epiphora. Imaging suggested nasolacrimal duct as probable site of origin.
View Article and Find Full Text PDFVirchows Arch
March 2024
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Indian J Pathol Microbiol
April 2024
Department of Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Indian J Pathol Microbiol
April 2024
Ophthalmology, M. and J. Western Regional Institute of Ophthalmology Affiliated to B. J. Medical College, Civil Hospital, Ahmedabad, Gujarat, India.
Skin adnexal or sweat gland neoplasms are rare adnexal tumors that pose a diagnostic challenge for both ophthalmologists and pathologists. Endocrine mucin-producing sweat gland carcinoma (EMPSGC) is an uncommon low grade carcinoma of eccrine ducts with a predilection to occur in the periocular region in the elderly female. We present a rare case of 65-year-old healthy male who presented with a lobulated mass in the left eye lower lid, clinically suspected as sebaceous gland carcinoma, diagnosed as endocrine mucin-producing sweat gland carcinoma histopathologically.
View Article and Find Full Text PDFEar Nose Throat J
February 2024
Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Jeonbuk National University School of Medicine, Jeonju, Korea.
World J Clin Cases
January 2024
Department of Plastic and Reconstructive Surgery, Konyang University Medical Center, Konyang University of College of Medicine, Daejeon 35365, South Korea.
Background: Porocarcinoma is a rare type of skin cancer that originates from sweat gland tumors. It is an aggressive malignant skin cancer that is difficult to diagnose clinically owing to its rarity and similarity to squamous cell carcinoma (SCC).
Case Summary: This case involved a 92-year-old woman, a farmer by profession, presented with an exophytic and verrucous mass on her left palm that had formed 2 years prior and caused chronic pain and frequent bleeding.
Ann Dermatol Venereol
March 2024
Cabinet de dermatologie, Docteur Carmi Esther, Amiens, France.
J Cutan Pathol
May 2024
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Biotech Histochem
February 2024
Department of Histology and Embryology, Firat University School of Medicine, Elazig, Turkey.
Squamous cell carcinoma (SCC) often develops from an underlying premalignant lesion. Factors that affect the progression of actinic keratosis (AK) to invasive SCC are not fully known. Asprosin (ASP) and meteorin-like peptide (METRNL) are adipokines that are involved primarily in glucose metabolism.
View Article and Find Full Text PDFAsian J Surg
March 2024
Department of Dermatology, The Second Affiliated Hospital of Guangdong Medical University, No. 12 Xiashan District Minyou Road, Zhanjiang, 524003, Guangdong Province, China. Electronic address:
J Cutan Pathol
March 2024
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Porocarcinomas are rare sweat gland cancers representing the malignant counterpart to benign poromas. Their diagnosis can be challenging, especially in the absence of an associated poroma or when the tumor is poorly differentiated. Since recurrent YAP1::MAML2 and YAP1::NUTM1 fusions have been identified in poroid tumors, molecular studies provide an opportunity to support the diagnosis in challenging cases.
View Article and Find Full Text PDFCase Rep Oncol
November 2023
Department of Medical Oncology, Wollongong Hospital, Wollongong, NSW, Australia.
Eccrine carcinoma, a subtype of which is ductal eccrine adenocarcinoma (DEA), is a rare cutaneous malignancy. For metastatic eccrine carcinoma, there are very limited data to guide treatment. Conventional chemotherapy is of limited benefit and there is only a small body of evidence for the use of immunotherapy in non-DEA eccrine carcinomas.
View Article and Find Full Text PDFOrbit
November 2023
Department of Ophthalmology and Visual Sciences, University of Adelaide, North Terrace, Australia.
Cylindroma is a rare benign tumour of eccrine origin that has not been previously reported within the orbit. We report a case of a recurrent orbital cylindroma following incomplete excision. A 75-year-old female presented with a recurrent left inferomedial orbital mass.
View Article and Find Full Text PDFArch Craniofac Surg
October 2023
Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Porocarcinoma (PC) and basal cell carcinoma (BCC) are distinct skin cancers. Few studies have documented the occurrence of two concurrent types of skin cancers, and to the best of our knowledge, this represents the inaugural report of such a coexisting lesion arising from a capillary malformation. Herein, we report a case of concurrent PC and BCC presenting with capillary malformation.
View Article and Find Full Text PDFArch Craniofac Surg
October 2023
Department of Plastic and Reconstructive Surgery, Daegu Fatima Hospital, Daegu, Korea.
Background: Preauricular sinus (PAS) is a common congenital anomaly, and complete excision is recommended to prevent recurrence. However, PAS has a high recurrence rate as a result of incomplete removal due to the high variability of the sinus ramifications, making its treatment challenging. In this study, we standardized the surgical procedure to reduce the complications and recurrence rate and compared the postoperative results between the non-standardized and the standardized groups.
View Article and Find Full Text PDFClin Cosmet Investig Dermatol
October 2023
Department of Dermatology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Eccrine poroma (EP) is a benign skin appendicular tumor that differentiates into the terminal sweat duct and is often differentiated from basal cell carcinoma (BCC) and seborrheic keratosis. This report describes a 58-year-old woman who presented with left occipital plaque. Histopathological analysis showed that the tumor cells were located in the lower part of the epidermis.
View Article and Find Full Text PDFDermatol Surg
October 2023
All authors are affiliated with the Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
J Am Podiatr Med Assoc
November 2023
¶Department of Podiatry, Boston University School of Medicine, Boston, MA.
Eccrine porocarcinoma is a rare malignant tumor of the eccrine sweat gland. This malignancy occurs most commonly in the lower extremities. It tends to occur in patients aged 60 to 80 years, affecting men and women equally.
View Article and Find Full Text PDFDermatol Surg
January 2024
Department of Dermatology, Lahey Hospital and Medical Center, Burlington, MA.
Cancers (Basel)
August 2023
Coordinator of the International Head and Neck Scientific Group, 35100 Padua, Italy.
Non-melanoma skin cancer (NMSC) represents the most common malignancy in the world, comprising exceedingly common lesions such as basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) and rare lesions such as Merkel cell carcinoma. Risk factors are widely recognized and include ultraviolet (UV) light exposure, radiation exposure, immunosuppression, and many others. As a whole, survival and functional outcomes are favorable, but each histopathological subtype of NMSC behaves differently.
View Article and Find Full Text PDFJ Cutan Pathol
November 2023
Department of Pathology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Cureus
July 2023
Surgical Oncology, Instituto Português de Oncologia do Porto, Porto, PRT.
Clear-cell hidradenocarcinomas are extremely uncommon sweat gland tumors with a predilection for the head and neck. In the limited number of articles reporting breast involvement, the primary focus concerns this entity's histological and immunohistochemical characteristics. Since hidradenocarcinomas of the breast have the potential to resemble a primary breast carcinoma closely, diagnosis may be challenging.
View Article and Find Full Text PDFMedicina (Kaunas)
August 2023
Department of Orthodontics, Faculty of Dental Medicine, Medical University Sofia, 1431 Sofia, Bulgaria.
Cutaneous mixed tumor is a rare benign neoplasm that exhibits a wide range of metaplastic changes and differentiation in the epithelial, myoepithelial, and stromal components, which is often confused with various other skin lesions. We present an unusual case of a 58-year-old woman with a mixed tumor of the upper lip, previously misdiagnosed as adnexal carcinoma on a preoperative biopsy. The excision biopsy shows a well-circumscribed lesion composed of various cells and structures featuring folliculo-sebaceous differentiation embedded in a prominent chondromyxoid stroma.
View Article and Find Full Text PDFHistopathology
January 2024
CARADERM, French Network of Rare Cutaneous Cancer, Lille, France.
Poroma is a benign sweat gland tumour showing morphological features recapitulating the superficial portion of the eccrine sweat coil. A subset of poromas may transform into porocarcinoma, its malignant counterpart. Poroma and porocarcinoma are characterised by recurrent gene fusions involving YAP1, a transcriptional co-activator, which is controlled by the Hippo signalling pathway.
View Article and Find Full Text PDFEur J Dermatol
June 2023
Department of Dermatology and Venereology, Centro Hospitalar Universitário de São João, Porto, Portugal.
Background: Hidradenocarcinoma is a rare malignant sweat gland tumour, characterized by a slow but aggressive course, with high rates of local recurrence and metastasis. Due to its rarity, histological criteria and therapeutic guidelines are poorly defined, posing a major challenge for clinicians and pathologists.
Objectives: To present two new cases of metastatic hidradenocarcinoma as well as a review of the literature.